The most well known genetic alteration in neuroblastoma is the amplification of the MYC-related oncogene (MYCN) [1,2], which is still the only prognostically significant oncogene amplification in neuroblastoma [3,4]. This evidence concerns the gene MYCN and neuroblastoma.